Verve Therapeutics, Inc.
2022 Q2 - 2025 Q2 (13 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q2 | 8/13/2025 | 163 | 0.0% | 14,490 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 66 | 0.0% | 14,490 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 82 | 0.0% | 14,490 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 70 | 0.0% | 14,490 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 71 | 0.0% | 14,490 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 212 | 0.0% | 14,720 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 202 | 0.0% | 14,490 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 192 | 0.0% | 14,490 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 270 | 0.0% | 14,400 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 212 | 0.0% | 14,720 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 285 | 0.0% | 14,720 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 507 | 0.0% | 14,760 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 295 | 0.0% | 19,320 | 6/30/2022 |